title: Chronic hepatitis B treatment with lamivudine in kidney transplant patients.
authors.affiliation: Kidney and Pancreatic Transplantation Unit, Pitié Salpêtrière Hospital, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Mouquet
authors.forename: B
authors.initials: B
authors.lastname: Bernard
authors.forename: T
authors.initials: T
authors.lastname: Poynard
authors.forename: V
authors.initials: V
authors.lastname: Thibault
authors.forename: P
authors.initials: P
authors.lastname: Opolon
authors.forename: P
authors.initials: P
authors.lastname: Coriat
authors.forename: M O
authors.initials: MO
authors.lastname: Bitker
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D011183:Postoperative Complications; D012189:Retrospective Studies
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D019259:Lamivudine; D016572:Cyclosporine